49
https://pubmed.ncbi.nlm.nih.gov/38091634
Lipid nanoparticles delivering siRNA to silence CXCL12 reduce type-I interferon production and modulate brain immune response during Zika virus infection, but also cause grip strength deficits potentially due to increased pro-inflammatory cytokines.